Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral SA001 for safety and efficacy in Dry Eye Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• SA001

Snippet

Sponsor: Samjin Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED